bibtype J - Journal Article
ARLID 0557330
utime 20240111141105.4
mtime 20220516235959.9
SCOPUS 85129879793
WOS 000793383600002
DOI 10.1038/s41598-022-11250-4
title (primary) (eng) Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose
specification
page_count 12 s.
serial
ARLID cav_un_epca*0386594
ISSN 2045-2322
title Scientific Reports
volume_id 12
publisher
name Nature Publishing Group
keyword covid-19
keyword vaccine efficacy
keyword inter-dose period
keyword epidemic modelling
keyword vaccination
keyword second dose delay
author (primary)
ARLID cav_un_auth*1103974
name1 Berec
name2 Luděk
institution BC-A
full_dept (cz) ENTU - Ekologie
full_dept (eng) Ecology
full_dept Insect Ecology
garant K
fullinstit Biologické centrum AV ČR, v. v. i.
author
ARLID cav_un_auth*0072028
name1 Levínský
name2 R.
country CZ
author
ARLID cav_un_auth*0430347
name1 Weiner
name2 J.
country CZ
author
ARLID cav_un_auth*0101206
name1 Šmíd
name2 Martin
institution UTIA-B
full_dept (cz) Ekonometrie
full_dept Department of Econometrics
department (cz) E
department E
full_dept Department of Econometrics
fullinstit Ústav teorie informace a automatizace AV ČR, v. v. i.
author
ARLID cav_un_auth*0100794
name1 Neruda
name2 Roman
institution UIVT-O
full_dept (cz) Oddělení strojového učení
full_dept Department of Machine Learning
full_dept Department of Machine Learning
fullinstit Ústav informatiky AV ČR, v. v. i.
author
ARLID cav_un_auth*0231277
name1 Vidnerová
name2 Petra
institution UIVT-O
full_dept (cz) Oddělení strojového učení
full_dept Department of Machine Learning
full_dept Department of Machine Learning
fullinstit Ústav informatiky AV ČR, v. v. i.
author
ARLID cav_un_auth*0402629
name1 Suchopárová
name2 Gabriela
institution UIVT-O
full_dept (cz) Oddělení strojového učení
full_dept Department of Machine Learning
country CZ
fullinstit Ústav informatiky AV ČR, v. v. i.
source
source_type textový soubor
url https://www.nature.com/articles/s41598-022-11250-4.pdf
cas_special
project
project_id TL04000282
agency GA TA ČR
country CZ
ARLID cav_un_auth*0414828
abstract (eng) Following initial optimism regarding potentially rapid vaccination, delays and shortages in vaccine supplies occurred in many countries during spring 2021. Various strategies to counter this gloomy reality and speed up vaccination have been set forth, of which the most popular has been to delay the second vaccine dose for a longer period than originally recommended by the manufacturers. Controversy has surrounded this strategy, and overly simplistic models have been developed to shed light on this issue. Here we use three different epidemic models, all accounting for then actual COVID- 19 epidemic in the Czech Republic, including the real vaccination rollout, to explore when delaying the second vaccine dose by another 3 weeks from 21 to 42 days is advantageous. Using COVID-19-related deaths as a quantity to compare various model scenarios, we find that the way of vaccine action at the beginning of the infection course (preventing infection and symptoms appearance), mild epidemic and sufficient vaccine supply rate call for the original inter-dose period of 21 days regardless of vaccine efficacy. On the contrary, for the vaccine action at the end of infection course (preventing severe symptoms and death), severe epidemic and low vaccine supply rate, the 42-day inter-dose period is preferable, at any plausible vaccine efficacy.
result_subspec WOS
RIV FN
FORD0 30000
FORD1 30100
FORD2 30102
reportyear 2023
num_of_auth 7
mrcbC47 UIVT-O 10000 10200 10201
mrcbC47 UTIA-B 10000 10200 10201
mrcbC55 UIVT-O IN
inst_support RVO:60077344
inst_support RVO:67985556
inst_support RVO:67985807
permalink https://hdl.handle.net/11104/0333827
mrcbC62 1
cooperation
ARLID cav_un_auth*0349694
name Jihočeská univerzita České Budějovice
institution JU České Budějovice
country CZ
confidential S
article_num 7638
mrcbC91 A
mrcbT16-e MULTIDISCIPLINARYSCIENCES
mrcbT16-j 1.132
mrcbT16-s 0.973
mrcbT16-D Q2
mrcbT16-E Q2
arlyear 2022
mrcbU14 85129879793 SCOPUS
mrcbU24 35538118 PUBMED
mrcbU34 000793383600002 WOS
mrcbU56 textový soubor
mrcbU63 cav_un_epca*0386594 Scientific Reports 2045-2322 2045-2322 Roč. 12 č. 1 2022 Nature Publishing Group